Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Price History  |  Ratios  |  Insiders

Stock Quote Today & Recent News STAAR Surgical Company STAA

STAAR Surgical Company, together with its subsidiaries, designs, develops, manufactures, and sells implantable lenses for the eye and accessory delivery systems to deliver the lenses into the eye. The company provides implantable Collamer lens product family (ICLs) and laser-based procedures, such as LASIK to treat visual disorders, such as myopia, hyperopia, astigmatism, and presbyopia. It... see more

Current News (NDAQ:STAA)

Broadwood Partners Comments on STAAR Surgical Shareholders' Rejection of the Company's Proposed Sale to Alcon

Business Wire 6 days ago

STAAR Surgical Announces Preliminary Results of Special Meeting of Stockholders

Business Wire 6 days ago

Broadwood Partners Denounces STAAR Surgical's Fourth Delay of the Shareholder Vote on the Company's Proposed Sale to Alcon

Business Wire December 19, 2025

Alcon Exercises Right to Require STAAR Surgical to Adjourn its Special Meeting of Stockholders

Business Wire December 19, 2025

Broadwood Partners Issues Open Letter to STAAR Surgical Board Pledging Cooperation and Support When Vote on Alcon Transaction Fails

Business Wire December 17, 2025

STAAR Stockholders Have a Choice: Vote FOR Alcon's Certain, Premium $30.75 Per Share Cash Offer or Bear the Downside Risk that Broadwood Has No Credible Plan to Create Stockholder Value

Business Wire December 17, 2025

Yunqi Capital Comments on Proxy Advisors' Updated Recommendations, Urges Shareholders to Continue to Back the Company's Standalone Trajectory

Business Wire December 16, 2025

Independent Industry Analysts Recognize Value Provided to STAAR Stockholders by Amended Alcon Merger Agreement and Merits of Alcon Transaction

Business Wire December 16, 2025

Broadwood Partners Comments on ISS Report on Proposed Sale of STAAR Surgical to Alcon

Business Wire December 16, 2025

Opinion & Analysis (NDAQ:STAA)

No current opinion is available.

Bullboard Posts (NDAQ:STAA)

Sell buddy sell.Wow.

Otherwise you guys out there will be losing your money with this stock today anyway
coolfooldumbguy - 6 days ago

STAAR Surgical Continues to Outperform with Robust Q1 2024 R

http://beyondspx.com/2024/08/02/staar-surgical-continues-to-outperform-with-robust-q1-2024-results/
MikeTester - August 3, 2024

$iMIN making moves in Ethereum Crypto !! 🚀🚀🚀🚀🚀

iMining Launches Fractional Staking to Enable Retail Investors to Participate in Ethereum 2.0's Proof-Of-Stake Mining Vancouver...
Saaaa1 - May 6, 2021

Anybody home?

Looks like some insiders buying the last few days, Somebody knows something the general public doesnt, Anybody care to comment.
numnuts101 - September 9, 2009

Podcasts